1. Home
  2. LPSN vs TNYA Comparison

LPSN vs TNYA Comparison

Compare LPSN & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

HOLD

Current Price

$5.15

Market Cap

84.5M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.85

Market Cap

234.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPSN
TNYA
Founded
1995
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.5M
234.8M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
LPSN
TNYA
Price
$5.15
$0.85
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
N/A
$8.00
AVG Volume (30 Days)
221.0K
5.1M
Earning Date
11-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$257,660,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.47
$0.36
52 Week High
$31.20
$3.69

Technical Indicators

Market Signals
Indicator
LPSN
TNYA
Relative Strength Index (RSI) 50.75 29.07
Support Level $4.63 $1.34
Resistance Level $5.49 $1.46
Average True Range (ATR) 0.30 0.10
MACD -0.00 -0.01
Stochastic Oscillator 50.86 7.87

Price Performance

Historical Comparison
LPSN
TNYA

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Share on Social Networks: